Femasys Recently Up 7% After Brief Volatility Pause

By Josh Beckerman

Femasys Inc. shares recently traded up 7% to $4.79. The stock peaked at $5.64 Wednesday and was briefly paused due to volatility.

Femasys produces the FemVue device for fallopian tube assessment. Its two lead product candidates are FemBloc permanent birth control and FemaSeed localized directional insemination for infertility.

The company’s June initial public offering priced at $13.

Write to Josh Beckerman at josh.beckerman@wsj.com

Kostenlose Erotik | Kostenlose Porno Film | Kostenlose Sex Chat | Kostenlose Sex Chat |